ArticleSaudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society
Lacrimal sac tumors: A case series over 27 years.
Article in Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis study aims to document and analyze the clinical characteristics, diagnostic approaches, and treatment outcomes of lacrimal sac tumors in a tertiary eye hospital in Saudi Arabia.
methodsA retrospective review was conducted of medical records from patients presenting with lacrimal sac tumors at King Khaled Eye Specialist Hospital between 1997 and April 2024. Demographic data, presenting symptoms, diagnostic imaging results, histopathological diagnoses, treatment modalities, and follow-up outcomes were analyzed.
resultsA case series of 13 patients with histopathologically confirmed lacrimal sac tumors was included in the study. The cohort consisted of 6 males and 7 females, with a mean age of 42 years. The majority of tumors were benign (61.5%), with atypical lymphoid hyperplasia being the most common (46%). Malignant tumors comprised 38% of cases, including squamous cell carcinoma and various lymphomas. Common presenting symptoms were epiphora (92%) and medial canthal swelling (68.4%). Surgical excision was the primary treatment modality, supplemented by radiotherapy for lymphomas. The overall recurrence rate was 15%, with no direct tumor-related mortality observed.
conclusionLacrimal sac tumors in this population predominantly presented as benign lesions, with a lower malignancy rate compared to previous reports. The study highlights the importance of early diagnosis and individualized treatment strategies. Future research with larger sample sizes and longer follow-up periods is necessary to develop standardized management protocols and improve patient prognoses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.